Categories
Alemtuzumab Anticancer Drugs Medicine Oncology Pharmacology Physiotherapy

Alemtuzumab

In this article we will discuss Alemtuzumab
(Dosage Overview)

In this article, we will discuss Alemtuzumab (Dosage Overview). So, let’s get started.

Indications

Alemtuzumab is indicated for the treatment of patients with relapsing forms of multiple sclerosis (MS). Because of its safety profile, the use of Alemtuzumab should generally be reserved for patients who have had an inadequate response to two or more drugs indicated for the treatment of MS.

Dosage

Dosage Information
The recommended dosage of Alemtuzumab is 12 mg/day administered by intravenous infusion for 2 treatment courses:
• First Treatment Course: 12 mg/day on 5 consecutive days (60 mg total dose)
• Second Treatment Course: 12 mg/day on 3 consecutive days (36 mg total dose) administered 12 months after the first treatment course.

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.